Dueñas Sadornil, María Del Carmen | Aparato Digestivo

Resultados: 99
Tipo Título / Nombre Autor(es) Año
Adherence to endoscopic surveillance guidelines for advanced lesions and colorectal cancer in Inflammatory Bowel Disease in Spain: a collaborative study of AEG and GETECCU Ballester Ferré MP, Mesonero F, Flórez-Díez P, Gómez C., Fuentes-Valenzuela E..., Dueñas C 2021
Influence of concomitant immunosuppresives in retention rate in Crohn´s Disease patients under ustekinumab in the SUSTAIN Study Chaparro M, Bastón Rey I, Fernández-Salgado E, González García J, Ramos L..., Dueñas C 2021
Influence of Crohn´s Disease phenotype in the retention rate of ustekinumab treatment: SUSTAIN Study Chaparro M, Bastón Rey I, Fernández-Salgado E, González García J, Ramos L..., Dueñas C 2021
Impact of biological agents on postoperative complications in inflammatory bowel disease: a multicentre study of GETECCU Rivero M, Miranda-Bautista J, Bastón-Rey I, Mesonero F..., Dueñas C 2021
Allysine and ?-Aminoadipic Acid as Markers of the Glyco-Oxidative Damage to Human Serum Albumin under Pathological Glucose Concentrations Luna C, Arjona A, Dueñas C, Estevez M 2021
Long-term effectiveness and safety of ustekinumab (UST) in patients with active Crohn’s disease (CD) in real life: Interim analysis of the SUSTAIN study Chaparro M, Sulleiro S, Bastón-Rey I, Rodríguez C, García-Tercero..., Dueñas C 2020
Long-term evolution after anti-TNF discontinuation in patients with inflammatory bowel disease (IBD): A multicentre study Casanova MJ, Chaparro M, Nantes O, Benítez JM, Rojas Feria M..., Dueñas C 2020
Long-term effectiveness and safety of ustekinumab (UST) in patients with active Crohn’s disease (CD) in real life: Interim analysis of the SUSTAIN study Chaparro M, Sulleiro S, Bastón-Rey I, Rodríguez C, García-Tercero I, Ramírez P, García López S, Rojas-Feria M, Gutiérrez A, Huguet Malavés JM, García-Sepulcre MF, Sicilia B, Bermejo F, Rodríguez-Moranta F, Argüelles F, Marín I, Leo E, Arroyo M, García MJ, Vázquez JM, Ginard D, Martínez Cadilla J, Rubín de Célix C, García-Herola A, Henández-Camba A, MartínArranz MD, Riestra S, Varela P, Velayos B, Busquets D, Dueñas C, Fernández Salgado E, Martínez-Montiel P, Diz-Lois MT, González-Lama Y, Muñagorri A, Navarro-Llavat M, Guisado D, Barreiro de Acosta M, Gisbert JP 2020
Long-term evolution after anti-TNF discontinuation in patients with inflammatory bowel disease (IBD): A multicentre study Casanova MJ, Chaparro M, Nantes O, Benítez JM, Rojas-Feria M, Castro-Poceiro J, Huguet JM, Martín-Cardona A, Aicart M, Tosca J, Martín Rodríguez MDM, González-Muñoza C, Mañosa M, Leo-Carnero E, Lamuela L, Pérez Martínez I, Bujanda L, Hinojosa J, Pajares R, Argüelles Arias F, Pérez Calle JL, Rodríguez González GE, Guardiola J, Barreiro de Acosta M, Bermejo F, Barrio J, Beltrán B, Gomollón F, Lorente R, Gutiérrez A, Domínguez Cajal M, Dueñas C, Ponferrrada Díaz A, Van Domselaar M, Ramírez de la Piscina P, Ramos L, Almela P, Navarro Llavat M, Botella B, Gisbert JP 2020
Lanreotide como tratamiento de rescate en la hemorragia digestiva de origen oscuro Martín Holgado D, Mata Romero P, López Núñez A, González Cordero PL, Ferreira Nossa HC, Hernández Alonso M, Robledo Andrés P, Dueñas Sadornil C, Molina Infante J 2019